|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/26 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3593814 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19185836.4 |
| Date of filing the European patent application | 2013-06-11 | |
| (97) | Date of publication of the European application | 2020-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2026-01-21 |
| (46) | Date of publication of the claims translation | 2026-04-27 |
| (30) | Number | Date | Country code |
| 201261658472 P | 2012-06-12 | US |
| (72) |
Cosenza, Marta , CH
Stark, Christoph , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūno kompozicija |
| ANTIBODY FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2026-05-19 | 14 | 289.00 EUR |
| 2027-06-11 |